The yellow fever 17D vaccine virus: Molecular basis of viral attenuation and its use as an expression vector

被引:17
|
作者
Galler, R [1 ]
Freire, MS [1 ]
Jabor, AV [1 ]
Mann, GF [1 ]
机构
[1] FIOCRUZ MS, LAB TECNOL VIROL, INST TECNOL IMUNOBIOL, BR-21045900 RIO DE JANEIRO, BRAZIL
关键词
flavivirus; yellow fever virus; attenuation; vaccine; gene expression;
D O I
10.1590/S0100-879X1997000200002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The yellow fever (YF) virus is the prototype flavivirus. The use of molecular techniques has unraveled the basic mechanisms of viral genome structure and expression. Recent trends in flavivirus research include the use of infectious clone technology with which it is possible to recover virus from cloned cDNA. Using this technique, mutations can be introduced at any point of the viral genome and their resulting effect on virus phenotype can be assessed. This approach has opened new possibilities to study several biological viral features with special emphasis on the issue of virulence/attenuation of the YF virus. The feasibility of using YF virus 17D vaccine strain, for which infectious cDNA is available, as a vector for the expression of heterologous antigens is reviewed.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 50 条
  • [1] 17D Yellow Fever Virus Vaccine
    Monath, Thomas P.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (06): : 1225 - 1225
  • [2] 17D Yellow Fever Virus Vaccine Response
    Edupuganti, Srilatha
    Mulligan, Mark J.
    Eidex, Rachel B.
    Cetron, Martin
    Marfin, Anthony A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2013, 89 (06): : 1226 - 1227
  • [3] Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections
    Neyts, J
    Meerbach, A
    McKenna, P
    DeClercq, E
    [J]. ANTIVIRAL RESEARCH, 1996, 30 (2-3) : 125 - 132
  • [4] The yellow fever 17D vaccine virus as a vector for the expression of foreign proteins: Development of new live flavivirus vaccines
    Bonaldo, MC
    Caufour, PS
    Freire, MS
    Galler, R
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2000, 95 : 215 - 223
  • [5] FATAL VIRAL ENCEPHALITIS FOLLOWING 17D YELLOW FEVER VACCINE INOCULATION
    不详
    [J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 198 (06): : 671 - &
  • [6] The early use of yellow fever virus strain 17D for vaccine production in Brazil - A review
    Post, PR
    de Carvalho, R
    Freire, MD
    Galler, R
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2001, 96 (06): : 849 - 857
  • [7] Evaluation of the Yellow Fever Virus Vaccine Strain 17D as a New Vector for HIV-1 Vaccine Development
    Franco, D.
    Rosas, C.
    Rice, C. M.
    Ho, D. D.
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 138 - 138
  • [8] A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
    Bredenbeek, PJ
    Molenkamp, R
    Spaan, WJM
    Deubel, V
    Marianneau, P
    Salvato, MS
    Moshkoff, D
    Zapata, J
    Tikhonov, C
    Patterson, J
    Carrion, R
    Ticer, A
    Brasky, K
    Lukashevich, IS
    [J]. VIROLOGY, 2006, 345 (02) : 299 - 304
  • [9] Stability of 17D Yellow Fever virus vaccine using different stabilizers
    Adebayo, AA
    Sim-Brandenburg, JW
    Emmel, H
    Olaleye, DO
    Niedrig, M
    [J]. BIOLOGICALS, 1998, 26 (04) : 309 - 316
  • [10] Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
    Franco, David
    Li, Wenjing
    Qing, Fang
    Stoyanov, Cristina T.
    Moran, Thomas
    Rice, Charles M.
    Ho, David D.
    [J]. VACCINE, 2010, 28 (35) : 5676 - 5685